Aurélien Bourdon

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

Marie‐Julie Nokin, Alessia Mira, Enrico Patrucco et al. · Nature Communications · 2024 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +4

The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features

Alexis Trécourt, Rihab Azmani, Isabelle Hostein et al. · Modern Pathology · 2023 · 29 citations

Medicine, Oncology, Pathology +14

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial

Antoîne Italiano, Derek Dinart, Isabelle Soubeyran et al. · BMC Cancer · 2021 · 23 citations · Full text

Medicine, Molecular Medicine, Oncology +14

CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications

Audrey Laroche‐Clary, Carlo Lucchesi, Christophe Rey et al. · Annals of Oncology · 2018 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition

Benjamin Fourneaux, Aurélien Bourdon, Bérengère Dadone et al. · Journal of Hematology & Oncology · 2019 · 17 citations · Full text

Medicine, Cancer Biology, Oncology +17